Stockscreener 앱 받기
0.4087
6.24%
-0.0272
시간 외 거래:
.42
0.0113
+2.76%
전일 마감가:
$0.4359
열려 있는:
$0.42
하루 거래량:
260.80K
Relative Volume:
0.57
시가총액:
$28.91M
수익:
-
순이익/손실:
$-126.61M
주가수익비율:
-0.2085
EPS:
-1.96
순현금흐름:
$-60.14M
1주 성능:
-5.26%
1개월 성능:
+9.72%
6개월 성능:
-81.34%
1년 성능:
-87.11%
1일 변동 폭
$0.4002
$0.449
1주일 범위
$0.4001
$0.454
52주 변동 폭
$0.316
$4.34
제너레이션 바이오 Stock (GBIO) Company Profile
명칭
Generation Bio Co
전화
857-529-5908
주소
301 BINNEY STREET, CAMBRIDGE
GBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
0.4087 | 28.91M | 0 | -126.61M | -60.14M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
제너레이션 바이오 Stock (GBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-10-19 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2021-12-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-07-07 | 개시 | Cowen | Outperform |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-07-07 | 개시 | Jefferies | Buy |
| 2020-07-07 | 개시 | Wedbush | Outperform |
모두보기
제너레이션 바이오 주식(GBIO)의 최신 뉴스
Layoff Tracker: BMS Closes Manufacturing Plant, Arvinas Axes One-Third of Staff - BioSpace
Renaissance Technologies LLC Has $1.02 Million Stock Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co [GBIO] stock for 120,759 USD was acquired by Quinn Anthony G. - knoxdaily.com
GBIO’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Generation Bio Co (GBIO) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Generation Bio Insiders Recover Some Losses, Which Stand At US$115k - simplywall.st
Generation Bio Co (NASDAQ: GBIO) Stock Is A Good Option To Consider - Stocksregister
Next-Generation Biomanufacturing Market Current Scenario with Future Trends Analysis to 2031 - openPR.com
Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World
GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia
GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa
LG Innotek, KAIST collaborate for next gen technology - 매일경제
Baker Hughes Co [BKR] Shares Rise 0.27 % on Wednesday - knoxdaily.com
Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times
Generation Bio Takes Center Stage: CEO Fireside Chat at Major Healthcare Conference - Stock Titan
Generation Bio stock hits 52-week low at $0.4 amid steep decline By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Cuts Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates - MSN
Generation Bio stock hits 52-week low at $0.47 By Investing.com - Investing.com South Africa
Generation Bio stock hits 52-week low at $0.47 - Investing.com India
Generation Bio’s (GBIO) Buy Rating Reaffirmed at Canaccord Genuity Group - Defense World
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution By Investing.com - Investing.com South Africa
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution - Investing.com Australia
Generation Bio’s (GBIO) Outperform Rating Reiterated at Wedbush - Defense World
Generation Bio Co. (NASDAQ:GBIO) Not Doing Enough For Some Investors As Its Shares Slump 29% - Simply Wall St
Generation Bio Co. Advances in Autoimmune Therapeutics - TipRanks
Generation Bio Co reports results for the quarter ended December 31Earnings Summary - TradingView
Generation Bio stock holds Market Perform rating at JMP - Investing.com India
Generation Bio stock holds Market Perform rating at JMP By Investing.com - Investing.com UK
Generation Bio earnings missed by $0.02, revenue topped estimates - Investing.com South Africa
Generation Bio Co (GBIO) Q4 2024 Earnings: EPS Misses Estimate o - GuruFocus.com
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position - Nasdaq
Generation Bio's Breakthrough: 98% T Cell Success Powers $185M Cash Runway Through 2027 - StockTitan
Generation Bio Co (GBIO)’s stock rises to 0.52 per share - US Post News
Generation Bio stock hits 52-week low at $0.52 By Investing.com - Investing.com Australia
제너레이션 바이오 (GBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):